BCL2 and cancer: Although the PERK pathway activates pro-apoptotic factors like DNA damage inducible transcript 3 (DDIT3) and B-cell lymphoma-2 (Bcl-2) family proteins, recent reports suggest that in cancer cells the balance is shifted toward pro-survival signaling [7,8].